Clinical management of nonhealing
ulcers requires advanced
materials
that can enhance wound closure rates without relying on the release
of drugs or other growth factors to obviate systemic deleterious side
effects. In our previous work, we synthesized an integrin-binding
cell adhesive M<sub>NH2</sub> {Fmoc-FFβAR(K)βA-NH<sub>2</sub> consisting of an RGD mimic, [R(K)], with an amide terminus},
M<sub>OH</sub> {Fmoc-FFβAR(K)βA-OH consisting of an RGD
mimic, [R(K)], with acid terminus}, and M<sub>R</sub> (Fmoc-FFβARGDβA-NH<sub>2</sub> consisting of an RGD peptide, reference) with multifunctional
activity. Here, we reported the synthesis, characterization, and performance
of a reversed derivative, R-M<sub>NH2</sub> (Fmoc-FFβA(K)RβA-NH<sub>2</sub> consisting of an RGD mimic, [K(R)], with an amide terminus)
of an antimicrobial cell adhesive peptide, M<sub>NH2</sub>. Both peptides
(M<sub>NH2</sub> and R-M<sub>NH2</sub>) were found to interact with
αvβ3 integrin, as shown by docking studies; however, they
differed in cell adhesive properties, hydrogel formation, and antimicrobial
efficacy. Later, the wound healing ability of a series of RGD/RGD
peptide mimics (M<sub>R</sub>, R-M<sub>NH2</sub>, M<sub>NH2</sub>,
and M<sub>OH</sub>) was studied in a methicillin-resistant Staphylococcus aureus (MRSA)-infected Balb/c mouse
model. All studied peptides showed cell adhesion and wound healing
properties; however, only the amide-terminal RGD peptide mimic, M<sub>NH2</sub>, and its reversed derivative, R-M<sub>NH2</sub>, showed
antimicrobial activity in both <i>in vitro</i> and <i>in vivo</i> studies. Of these, M<sub>NH2</sub> showed the highest
integrin-mediated spreading, migration, and proliferation of dermal
cells <i>in vitro</i> as well as <i>in vivo</i>. Therefore, the M<sub>NH2</sub> peptide mimic represents a paradigm
shift in the development of dermoconductive strategies to treat chronic
wounds.